Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
Use this NEUP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NEUP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NEUP SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuphoria Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NEUP income, balance, and cash tables.